|
|
|
|
|
|
|
|
|
|
| Other drug names: | A-Am An-Az B C-Ch Ci-Cz D-Dh Di-Dz E F G H I-J K-L M-Mh Mi-Mz N-Nh Ni-Nz O P-Pl Pm-Pz Q-R S-Sn So-Sz T-To Tp-Tz U-V W-Z 0-9 |
| Contents of this page: | |
Some commonly used brand names are:
In the U.S.--
In Canada--
Another commonly used name is desferrioxamine .
Deferoxamine (dee-fer-OX-a-meen) is used to remove excess iron from the body. This may be necessary in certain patients with anemia who must receive many blood transfusions. It is also used to treat acute iron poisoning, especially in small children.
Deferoxamine combines with iron in the bloodstream. The combination of iron and deferoxamine is then removed from the body by the kidneys. By removing the excess iron, the medicine lessens damage to various organs and tissues of the body. This medicine may be used for other conditions as determined by your doctor.
Deferoxamine is to be administered only by or under the immediate supervision of your doctor. It is available in the following dosage form:
In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For deferoxamine, the following should be considered:
Allergies--Tell your doctor if you have ever had any unusual or allergic reaction to deferoxamine. Also tell your health care professional if you are allergic to any other substances, such as foods, preservatives, or dyes.
Pregnancy--Deferoxamine has not been shown to cause birth defects or other problems in humans. However, in animal studies this medicine caused birth defects when given in doses just above the recommended human dose. In general, deferoxamine is not recommended for women who may become pregnant or for use during early pregnancy, unless the woman's life is in danger from too much iron.
Breast-feeding--It is not known whether deferoxamine passes into breast milk. Although most medicines pass into breast milk in small amounts, many of them may be used safely while breast-feeding. Mothers who are taking this medicine and who wish to breast-feed should discuss this with their doctor.
Children--Deferoxamine is not used for long-term treatment of children up to 3 years of age. Also, younger patients are more likely to develop hearing and vision problems with the use of deferoxamine in high doses for a long time.
Older adults--The combination of deferoxamine and vitamin C should be used with caution in older patients, since this combination may be more likely to cause heart problems in these patients than in younger adults.
Other medicines--Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are receiving deferoxamine, it is especially important that your health care professional know if you are taking the following:
Other medical problems--The presence of other medical problems may affect the use of deferoxamine. Make sure you tell your doctor if you have any other medical problems, especially:
Deferoxamine may sometimes be given at home to patients who do not need to be in the hospital. If you are receiving this medicine at home, make sure you clearly understand and carefully follow your doctor's instructions .
Dosing--The dose of deferoxamine will be different for different patients. Follow your doctor's orders or the directions on the label . The following information includes only the average doses of deferoxamine. If your dose is different, do not change it unless your doctor tells you to do so.
Storage--To store this medicine:
It is important that your doctor check your progress at regular visits to make sure that this medicine is working properly and to prevent unwanted effects. Certain blood and urine tests must be done regularly to check for the need for dosage changes.
Deferoxamine may cause some people, especially younger patients, to have hearing and vision problems within a few weeks after they start taking it. If you notice any problems with your vision, such as blurred vision, difficulty in seeing at night, or difficulty in seeing colors, or difficulty with your hearing, check with your doctor as soon as possible . The dose of deferoxamine may need to be adjusted.
Do not take vitamin C unless your doctor has told you to do so.
Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor as soon as possible if any of the following side effects occur:
More common
Bluish fingernails, lips, or skin; blurred vision or other problems with vision; convulsions (seizures); difficulty in breathing (wheezing), or fast breathing; fast heartbeat; hearing problems; pain or swelling at place of injection; redness or flushing of skin; skin rash, hives, or itching
Less common
Diarrhea; difficult urination; fever; leg cramps; stomach and muscle cramps; stomach discomfort; unusual bleeding or bruising
Hearing and vision problems are more likely to occur in younger patients taking high doses and on long-term treatment.
Deferoxamine may cause the urine to turn orange-rose in color. This is to be expected while you are using this medicine.
Other side effects not listed above may also occur in some patients. If you notice any other effects, check with your doctor.
Once a medicine has been approved for marketing for a certain use, experience may show that it is also useful for other medical problems. Although this use is not included in product labeling, deferoxamine is used in certain patients with the following medical condition:
Other than the above information, there is no additional information relating to proper use, precautions, or side effects for this use.
Revised: 06/22/2000
| Micromedex, Inc. Disclaimer |
| Health Topics | Drug Information | Dictionaries | Directories | Other Resources |
|
U.S. National Library of Medicine, 8600 Rockville Pike, Bethesda, MD 20894
Copyright and Privacy Policy, We welcome your comments. Last updated: 24 January 2001 |